Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients-Reference-Cited by-同舟云学术

Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients

Published:2023-02 Issue:2 Volume:29 Page:132.e1-132.e5
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Patel Chandni^ORCID,Pasciolla Michelle^ORCID,Abramova Rachel^ORCID,Salerno David,Gomez-Arteaga Alexandra^ORCID,Shore Tsiporah B.,Orfali Nina,Mayer Sebastian,Hsu Jingmei,Phillips Adrienne A.,Chaekal Ok-Kyong,Satlin Michael J.,Soave Rosemary,Kodiyanplakkal Rosy Priya L.^ORCID,Drelick Alexander,Plate Markus,Besien Koen Van^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference13 articles.

1. Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLD?;Savani;Blood,2009

2. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation;Landgren;Blood,2009

3. Rituxan [package insert],2010

4. Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT;Burns;Bone Marrow Transplant,2016

5. In vivo B-cell depletion with rituximab for alternative donor hematopoietic SCT;Dominietto;Bone Marrow Transplant,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes;Viruses;2024-08-14

2. Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity;Blood;2024-08-01

3. Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children;Frontiers in Immunology;2024-07-11

4. Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada;Current Oncology;2024-05-14

5. ОНОВЛЕНІ УЗАГАЛЬНЕНІ РЕКОМЕНДАЦІЇ З ЛІКУВАННЯ ГЕРПЕСВІРУСНИХ ІНФЕКЦІЙ ЛЮДИНИ;Journal of Dermatovenereology and Cosmetology named after N.A.Torsuiev;2024-02-08